Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
IGC launched this website today. https://www.holihemp.com
Best of luck!
-Game
MMs have been toying with walls on this for a few weeks now. Aleafia has made great progress in regards to continued growth and uplisting to TSX. Looking forward to what Aleafia and Emblem can bring together for future growth. Big things in the works, as well as uplisting to NASDAQ.
Awaiting shareholder updates regarding current security details and forward looking plans post merger. Holding these levels nicely in the meantime IMO. See 1 month and 3 month charts.
Welcome all Emblem shareholders!
Long and strong $ALEAF
All IMO. Best of luck all!
-Game
Nice support base forming here. 2 day close at $2.27. 3/8 & 3/12.
16:00 2.40 2.47 2.20 2.27 2,000,106
03/11/2019 2.34 2.54 2.1 2.41 1,759,518
03/08/2019 1.9 2.63 1.75 2.27 4,680,719
https://www.nasdaq.com/symbol/igc/historical
Exploded off these levels Sep/Oct last year. Positive forward moving news could send us?... Anywhere. Still looking forward to a nice run up IMO.
Best of luck all!
-Game
MM's are screwing with this one again...
TICK DIRECTION
03/06/2019 11:03:21 0.00001 200
03/05/2019 15:17:00 0.000001 120
https://www.otcmarkets.com/stock/INAR/overview
TDA showing 0.10x P/E ratio randomly... Not too sure why, as far as I can see nothing has been updated.
Still dreaming that something will come out of this..
-Game
Wonderful, continued forward moving progress shown here! Great news, thank you for posting!
$ALEAF long and strong.
Best of luck all!
-Game
Absorbing these 1.70's. Extremely undervalued mid/ long term IMO. $Aleaf
Best of luck all
-Game
Great movement here... Good chance we see a Historic move repeating itself IMO. GL IGCC
10/23/2018 2.25 3.2 2.16 3.1 11,886,360
10/22/2018 3.36 3.39 2.57 2.67 7,365,635
10/19/2018 4.15 4.15 3 3.18 8,971,433
10/18/2018 4.21 4.5 4.05 4.17 3,786,510
10/17/2018 4.45 4.49 4.07 4.17 4,683,127
10/16/2018 4.62 4.98 4.43 4.54 9,163,101
10/15/2018 4.67 5.45 4.42 5.26 13,161,790
10/12/2018 5.3 5.3 4.76 4.95 12,000,100
10/11/2018 4.7 4.96 4.4 4.45 7,823,364
10/10/2018 5.8 5.81 4.81 5.1 15,792,160
10/09/2018 5.21 5.63 4.8 4.82 17,256,600
10/08/2018 4.99 6.78 4.76 6.74 47,650,230
10/05/2018 4.8 5.34 3.97 4.05 29,853,320
10/04/2018 7 7.76 6.26 6.41 29,112,130
10/03/2018 9.5 10.78 8.55 8.85 41,127,220
10/02/2018 10.76 14.58 9.5 13 119,089,400
10/01/2018 8 9.24 7.16 9.02 61,394,080
09/28/2018 5.85 7.48 5.35 6.45 103,279,300
09/27/2018 3.61 4.71 3.35 4.6 51,925,420
09/26/2018 3.25 3.39 2.77 3.02 36,244,930
09/25/2018 2.68 2.81 2.3 2.33 6,506,263
09/24/2018 2.56 2.69 2.05 2.6 13,199,630
09/21/2018 2.7 4.06 2.6 2.9 76,264,480
09/20/2018 1.9 2.15 1.71 2.15 19,140,880
09/19/2018 1.68 1.9 1.54 1.69 22,620,670
https://www.nasdaq.com/symbol/igcc/historical
-Game
New updates to their webpage as well as a new manifesto video released yesterday.
https://aleafiahealth.com
Multiple year hold here IMO.
-Game
Aleafia quick DD teaser
Aleafia Health
“Aleafia’s unique patient-focused, healthcare solution and its substantial cultivation, research and clinical assets have created one of Canada’s leading, vertically integrated medical cannabis companies.”
Ticker Symbols:
TSX-V: ALEF (Canada exchange)
OTCQX: ALEAF (United States exchange)
Market Cap: 300.8M (2/3/19)
Outstanding Shares: 157.6M (2/3/19)
$20 million+ cash on hand as of Q3 2018
Board of Directors / Executive management
https://www.aleafiainc.com/board-of-directors
https://www.aleafiainc.com/executive-management
Medical Cannabis
A division of Aleafia Health, Canabo Medical Clinic (Canabo) is the country’s largest network of referral-only medical cannabis clinics. Since 2014, Canabo has expanded to help patients from St. John’s to Kelowna and currently has 20 clinics across Canada.
Leading patient care in medical authorizations for cannabinoids and medical cannabis, Canabo Medical Clinic uses these therapies to treat patients suffering from chronic pain and disabling illnesses. Canabo educates patients, physicians, and the community by advancing medical cannabis research.
https://aleafiahealth.com/health-and-wellness-services/
Aleafia and Serruya Private Equity Reach Agreement for National Retail Dispensary, top Performing Brands and $10M InvestmentPress Release | 11/21/2018
Transactions Positions Aleafia as Major Supplier, Retailer of Adult-use Cannabis
TORONTO, Nov. 21, 2018 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSXV: ALEF; OTCQX: ALEAF, FRA: ARAH) (“Aleafia“ or the “Company“), and Serruya Private Equity (“Serruya” and together with the Company, the “Parties”), have settled final forms of definitive joint venture and other agreements that will see the Parties launch a Canada-wide cannabis retail Joint Venture (“Retail JV”) along with a domestic and international cannabis brands Joint-Venture (“Brands JV”, and together with the Retail JV, the “Joint Venture”). Serruya will also make a $10 million strategic investment in Aleafia via a non-brokered private placement financing (“Private Placement”) and Aleafia will invest $5 million of such gross proceeds of the Private Placement into the Joint Venture.
The Brands JV will conduct business under the name “Flying High Brands Inc.” with Aleafia owning fifty-one percent (51%) and Serruya owning forty-nine percent (49%). The Joint Venture enables multiple income streams throughout the value chain, with Aleafia’s cultivation producing cannabis for processing, extraction, packaging and eventual listing in retail locations and with provincial distributors.
Additional Highlights:
Backed and supported with a $10 million investment by Serruya and its affiliate, International Franchise Inc., which has over 4500 quick service restaurant locations in over 50 countries
Serruya has also been a leading early cannabis industry force as cannabis industry investors in both emerging and established issuers and other industry participants
Launch approximately 20 proposed retail outlets, with a subsequent national and international expansion plan (excluding the U.S.)
With turn-key store launch, licensing agreements cover established, commercially proven international cannabis brands
Ready-made store design and retail systems in place, along with intellectual property including genetics and packaging
https://www.otcmarkets.com/stock/ALEAF/news/Aleafia-and-Serruya-Private-Equity-Reach-Agreement-for-National-Retail-Dispensary-top-Performing-Brands-and-10M-Investme?id=210983
Aleafia Health Inc. to Acquire Emblem Corp. to Create New Medical Cannabis LeaderPress Release | 12/19/2018
Combination will create Canada’s largest medical cannabis clinic network with access to 40 medical clinics and education centres;
Aleafia patients to access Emblem’s differentiated, high margin derivative products including capsules, oils and oral sprays, along with award-winning customer service and eCommerce platform;
Regulatory acceleration with Aleafia leveraging Emblem’s Health Canada License to extract and process medical cannabis products and sell them directly to patients;
Aleafia to become among national leaders in production capacity (including committed supply agreements);
Expansion of Aleafia’s national and global distribution platform;
Increased scale of the combined company will enhance its capital markets profile and increase trading liquidity; and
Combination results in current cash resources of approximately $70 million.
https://www.otcmarkets.com/stock/ALEAF/news/Aleafia-Health-Inc-to-Acquire-Emblem-Corp-to-Create-New-Medical-Cannabis-Leader?id=213670
Aleafia Health Completes Strategic Investment in Australia’s CannaPacific Pty Limited
By GlobeNewswire, January 18, 2019, 07:56:00 AM EDT
Vote up
AAA
Global Expansion Underway with 10% Equity Investment in Licensed Cannabis Cultivator
CannaPacific among Australia's only Federally Licensed Cultivators with projected 108,000 sq. ft. Greenhouse
TORONTO, Jan. 18, 2019 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSXV: ALEF: OTCQX: ALEAF, FRA: ARAH) ("AleafiaHealth") or the ("Company") is announcing its global expansion with the closing of its previously announced investment in CannaPacific Pty Limited ("CannaPacific"), a federally licensed Australian medical cannabis company located in New South Wales, Australia.
CannaPacific is licensed by the Office of Drug Control (ODC) of Australia to cultivate medical cannabis (License MC020/18) and to research medical cannabis (License RL 012/18). CannaPacific has also applied for a manufacturer's license which has been reviewed by the ODC.
The transaction was completed pursuant to the terms of an Investment Agreement (the "Investment Agreement") dated January 17, 2019 between CannaPacific, Aleafia Health and CannaPacific's founder shareholder, Dennis Partners Pty Limited as trustee for Dennis Partners Trust (the "Investment Agreement"). Under the Investment Agreement, Aleafia acquired 10% of the ordinary shares of CannaPacific from the Founder for AUS $100 and Aleafia agreed to contribute to CannaPacific USD $150,000 in working capital in two tranches of USD $75,000 over a six (6) month period. Aleafia also acceded to CannaPacific's Shareholders Agreement. The TSX Venture Exchange consented to the investment on January 16, 2019.
EARLY MOVER ADVANTAGE WITH 108,000 SQ. FT. GREENHOUSE
CannaPacific recently won the bid to acquire a horticultural property with extensive greenhouses and infrastructure. The property is situated in the iconic Byron Bay region of New South Wales. Upon closing of the property acquisition, CannaPacific will begin retrofitting of the facility, which boasts 108,000 sq. ft. (10,000 sq. m.) of greenhouse cultivation area. The acquisition significantly accelerates CannaPacific's early mover advantage in Australia's budding medical cannabis sector. The property also has local government approval for a subsequent 110,000 sq. ft. expansion of the facility. CannaPacific is currently preparing an amendment to their existing licences to conduct cultivation and research at this property.
CannaPacific aims to supply the Australian medical cannabis patients with pharmaceutical grade medical cannabis products. The market size is expected to grow from USD $52 million in 2018 to USD $1.2 billion in 2027, according to BDS Analytics. CannaPacific also intends to export medical cannabis, which was recently authorized by the Australian federal government.
CannaPacific's management is composed of veterans of medicine, pharmaceutical manufacturing and sales, oncology, hospital management, plant science and cannabis cultivation.
ALEAFIA HEALTH MEDICAL CANNABIS LEADERSHIP
Aleafia will assist CannaPacific in the establishment of dedicated medical cannabis clinics, with shared expertise across patient treatment and education, physician recruitment and training, treatment best practices and clinic operations.
Upon the closing of the Company's previously announced acquisition of Emblem Corp. (TSXV: EMC, OTCQX:EMMBF) ("Emblem"), expected in Q1 2019 following satisfaction of previously announced transaction conditions, CannaPacific will leverage Emblem's product innovation expertise, with a portfolio of high-margin derivate products including oils, capsules and sprays.
"This strategic investment in an emerging medical cannabis market marks Aleafia's first step towards a broader global expansion," said Aleafia Chairman Julian Fantino. "Much like Canada's medical cannabis industry a decade ago, early movers like CannaPacific featuring strong management, financial backing and technical expertise will capture significant market share."
"This transaction will place Aleafia at the epicentre of what we expect will be a major growth centre in the global medical cannabis market," said Aleafia CEO Geoffrey Benic. "Aleafia will soon boast global distribution networks in Germany (upon completion of the Emblem acquisition) and Australia, complementing our cannabis cultivation, clinics and adult-use retail in Canada."
"We are delighted to have Aleafia as a strategic investor," said CannaPacific CEO Joshua Dennis. "With a major cannabis cultivation facility and strategic relationship with medical cannabis leader, we expect to accelerate our first to market strategy in Australia along with our objective of becoming a major exporter of medical cannabis products."
https://www.nasdaq.com/press-release/aleafia-health-completes-strategic-investment-in-australias-cannapacific-pty-limited-20190118-00229
Quick progress video with Geoffrey Benic on Midas Letter live. 2/5/19
https://www.youtube.com/watch?v=n_ha7Bzv0f0
Aleafia Health CEO Geoffrey Benic on Smallcap Power. 2/11/19
https://www.youtube.com/watch?v=Q2CTOMbdYOQ
Aleafia Health CEO Geoffrey Benic on Smallcap Power. 2/11/19
Quick progress video with Geoffrey Benic on Midas Letter live. 2/5/19
GGII yield sign REMOVED. Pink current as I am seeing on otcmarkets now! Great sign IMO.
https://www.otcmarkets.com/stock/GGII/news/story?e&id=1148246
$GGII
Nice updates rolling out. Love the upside potential here with Aleafia and their current/new partnerships. Looking forward to a strong 2019 year here with this company!
Best of luck all, have a great weekend!
-Game
Nice group of traders here.. Joined the party Tuesday, added more today.
Nice support sitting @ 001 all week, chart screaming buy IMO.
Nice to see their profile verified 1/19. Looking forward to current status and updates.
Best of luck all
-Game
Nice movement today, thank you for the board news posts!
Stuck for years along with you my friend. Would be overjoyed to see anything at all happen here.
Definitely some odd action last few weeks here off of years of nothing. 16M ask is nice to see... We'll see if anything comes out of this. Best of luck!
Upon completion of the Transaction, two (2) independent directors of Emblem will be appointed to serve on the board of directors of Aleafia, being Daniel Milliard and Loreto Grimaldi who will replace two (2) directors of Aleafia.
Interesting... Curious as to whom Daniel Milliard and Loreto Grimaldi will be replacing.
The Agreement calls for Emblem shareholders to receive 0.8377 of an Aleafia common share (each whole share, an “Aleafia Share”) in exchange for each Emblem common share (each, an “Emblem Share”), representing the equivalent of $1.21 per Emblem Share and a premium of 27.0% based on the closing prices of Aleafia and Emblem Shares on the TSX Venture Exchange (“TSXV”) on December 18, 2018.
Another point of interest is how many shares will this conversion end up being? As well as pre or post RS assuming that will still go through.
Exciting continued growth here, looking forward to more detailed information.
Best of luck! $ALEAF
Nicely trading today. Hopefully $1.00 was our bottom out point. 2 days until SH meeting concerning RS. Could get interesting either direction IMO. Good luck!
Letter from Chairman Julian Fantino
DECEMBER 03 2018
Over the last month, Aleafia has made significant strides towards achieving our objective of providing the best possible care for our patients, and in turn, providing real value for our shareholders.
Our Third Quarter results marked a series of important milestones for Aleafia. During the reporting period, our first cannabis sale provided a significant boost to Aleafia’s revenue, leading to a 36 per cent increase over the previous quarter.
Meanwhile, our clinic business has undergone a series of important changes that will ensure we reach the broadest possible number of patients. These include expanded telemedicine offerings and the recruitment of new physicians and nurse practitioners to handle an increase in patient volume.
Our major cannabis cultivation operations will see us produce 98,000 kg of cannabis per year starting in 2019, positioning us among the largest Licensed Producers in Canada.
While we will remain relentlessly focused on the execution of these initiatives, it is important that Aleafia secures a platform in which we can tell this story to the broadest network of investors possible. For Aleafia, that means securing a listing on the NASDAQ Stock Exchange.
Successfully listing on a major US stock exchange would broaden Aleafia’s shareholder base, and increase appeal to institutional investors. Most importantly, we believe that securing a NASDAQ listing will provide a significant, lasting benefit to you, our shareholders.
With that objective in mind, Aleafia has asked for shareholder support to allow for a consolidation of Aleafia’s common and outstanding shares. This will assist in ensuring Aleafia meets NASDAQ’s minimum share price requirement.
In order for this to proceed, we require shareholder approval to secure the NASDAQ listing at a time that will most benefit shareholders.
There are three items I would like to make completely clear to our investors:
Aleafia will only pursue a share consolidation if it is deemed necessary to meet NASDAQ requirements. This resolution simply allows the flexibility to pursue this option at an advantageous time for Aleafia’s shareholders.
If a share consolidation is enacted, it will not have an effect on the percentage ownership of each individual shareholder or the company.
We may not need to pursue a consolidation.
This last point is critical. Firstly, we will only pursue a consolidation if it is absolutely necessary to secure a listing on NASDAQ. Secondly, if we do pursue a consolidation, we will do so at the minimum ratio necessary to reach our objective of the listing.
As we move closer towards achieving our stated objective of securing a listing on NASDAQ, Aleafia is better positioned than ever. And as we continue to relentlessly focus on executing our business strategy, we look forward to making a major step, with you, our shareholders, towards a global leadership position among the top cannabis companies in the world.
Sincerely,
Julian Fantino
Fantino, Julian Signature
Chairman, Aleafia Health Inc.
NOTE: Shareholders may contact ComputerShare at 1-800-564-6253 for assistance with voting in the December 6, 2018 Special Meeting of Shareholders.
https://www.aleafiainc.com/investor-news/aleafia-chairman-letter
Sad to see this continue to drop here. Still don't believe they need to RS but as far as the chart is looking it'll need to hold around $1.25 or lookout below towards $0.80 IMO. Still a dangerous game in the OTC without continued support. Watching from the sidelines until SH meeting on 12/6. Best of luck all
The opportunity here with Aleafia and their board of directors is extremely intriguing. I have to agree with you generally about being cautions pre RS. Really hoping they vote against it. Profit and growth should easily push them within NASDAQ requirements with due time. Seeing as that is one of their current goals. Not too sure why they feel they're current SS is too high... 145M OS... 22.8M cash on hand... Only point of interest I'm extremely cautious about is the "unlimited authorized", a slight restructure to cap that along with the float and ALEAF could run hard. Maybe I'm not quite understanding why the feel the need for an RS at this point.
3+ years stuck and waiting... Lmao
Jumped in @ open here. Looking good gents. Best of luck! TLPY
MAXM hasn't moved off 004 for days. He can feel free to dilute there, everyone would be up several hundred percent by then anyway... L2 turning. Looking stronger here IMO. Best of luck all LCLP
MNKD heating up again!? Nice 16% green here currently. Best of luck all
Hello all, new here with FSDDF. Liking the potential here with this company. Unlimited authorised shares though? That is unsettling concerning that they also trade under HUGE and might not have any reason to do anything but dilute this US ticker.. input?
Thanks and best of luck!
Presenting @ Rodman & Renshaw 20th Annual Global Investment Conference today. I'm sure they'll announce their newly inked deal there as well. More and more eyes, don't count this out yet IMO... MNKD
Thank you my friend! Looking good here, solid DD all around and a nice veteran team of traders and investors already aboard. Looking forward to new info released from the company, seems to have a nice management team running behind the scenes.
I don't even mind that they are not too concerned with share price at the moment... Would rather have management focused on growth and company fundamentals rather than shareholder drama any day! Best of luck to you and all holding UCPA!
PB, thank you for your well thought-out and educated response! Finding companies with true forward moving progress as well as honest reporting practices down in pinky otc is few and faaaar between. We're all aware of that fact.. UCPA does have a multitude of positive attributes supporting that we have a diamond in the rough here.
Thanks again for your time and best of luck to you my friend. Marked you! I will be locking up a portion here as well.
PB, although I fully agree with you on UCPA's superior verified fins... You're comparing a run to D*RV who has half the AS, 1/8th the OS and a MC of 1.1M compared to UCPA's 14.5M MC. Why would you assume that a larger run would occur here?
I have been quietly observing from the sidelines, compiling DD that I can thus far assume to be true with UCPA. All of which supports a strengthening opinion that UCPA has the opportunity to be a great long term hold... Although I am hesitant to see where this has the opportunity to see a large percentage gain short term. Without a massive new following of investors here, I am failing to see where a large run would occur from. Due to the fact that current investors have already seen the fins and have not already amassed personal large holdings.
I need to reiterate that I am leaning towards agreeing that UCPA has the potential to be a great investment on a long term outlook, just curious why you are comparing them to an over hyped over promoted company such as D*RV?
All above is IMO. Best of luck!
Added as well, mmm so tasty at these levels. $MLTC looking forward to updates rolling in. Best of luck all
Who dumped last min? Thanks for the .051s! Will be continuing to add here. Best of luck all!
Random 1K share volume last 2 days..
001-005 loaders dumping this?
Not enough eyes here. Do they only post updates and PRs through IHUB newswire? SS seems tight enough to run, just needs more attention here IMO. Best of luck! $DIRV
See post 34351, 6th picture down for bay 2 trimmed prior to this harvested picture.
$SIGO
SIGO SH tour 3/8/18 pics and brief info
Hello everyone, I am still on vacation so this is going to be short and sweet. Quick points of interest.
-10-12 days to root the clones per Chris.
-Plants are grown in coconut husk.
-80-120 lbs per bay (per level) expected under Chris's method.
-Expected to raise to 3 levels per bay. They are currently working on trimming and training the plants so that they will flower within a much shorter plant.
-Flower periods are 9 weeks.
-Clone to harvest 13 weeks.
-Stan believes there is more money in extracts based on yield.
-New extraction equipment coming in this week per Stan.
-Currently growing 10 different strains.
-Their greenhouse is located on a shared plot of land with several other companies, of which most are growing marijuana that I could see. Looks to be a nice location, simple, non flashy grow space which is nicely organized.
Clone rooting room
Strain exam tables
Chris running through the mother plants
Various bay stages
Various bay stages
Various bay stages
Flowering
Stan running through the extraction process
Retrofit design plans
Best of luck $SIGO
-Game
I will be flying in to attend the SH tour on the 8th. Anyone who is shouting out doom and gloom, I hope you attend as well. The progress made here over the past 2 years in terms of share structure consolidation, moving from pinks to QB, land and equipment purchases, and open communications has been substantial IMO. Everyone is crying about the financing deal and ignoring the AS change from 100M to 20M total shares? Seems as though the company is doing what they can to expand business without diluting the SS to me... Thats normal in penny land correct? Ha. Just to clarify I am also awaiting the documented proof of said AS change.
Show me another penny runner that involves their shareholders in tours of their newly started and expanding facilities... Dealing with a product that has an already fully established market and a non saturated legal distribution set into place.
You can't trust anything involved with companies listed this low down in the markets, at least SIGO will let you view their progress with your own eyes and make your decision from there.
Best of luck all
$SIGO